Why the study?
Do triglyceride-lowering therapies reduce coronary heart disease risk in patients with hypertriglyceridemia?
Population
Patients with hypertriglyceridemia
Design
Review
Authors
Loading...
Triglyceride-lowering should not guide CHD prevention; leaves open whether it reduces risk independently.
Do triglyceride-lowering therapies reduce coronary heart disease risk in patients with hypertriglyceridemia?
This review highlights that while hypertriglyceridemia is a theoretical risk factor for CHD, its independent contribution and the clinical benefit of triglyceride-lowering for CHD prevention remain controversial.
Geurian et al. (1992) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: